tm
Seeing Is Believing
tm
Seeing Is Believing
Currently out of the existing stock ratings of David Low, 4 are a HOLD (19.05%), 15 are a BUY (71.43%), 2 are a SELL (9.52%).
Analyst David Low, currently employed at JPMORGAN, carries an average stock price target met ratio of 82.35% that have a potential upside of 11.39% achieved within 314 days.
David Low’s has documented 38 price targets and ratings displayed on 1 stocks. The coverage is on the Healthcare sector.
Most recent stock forecast was given on RMD, ResMed at 31-Jan-2025.
Analyst best performing recommendations are on RMD (RESMED).
The best stock recommendation documented was for RMD (RESMED) at 5/21/2021. The price target of $219 was fulfilled within 24 days with a profit of $21.92 (11.12%) receiving and performance score of 4.63.
Average potential price target upside
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date
Price targets met ratio
Average potential upside
Average Time (Days) For PT To Be Met
Performance score
Hold
8 days ago
(31-Jan-2025)
11/11 (100%)
$-8.75 (-3.58%)
211
Buy
$286
$49.06 (20.71%)
$195
8 days ago
(31-Jan-2025)
14/17 (82.35%)
$28.35 (11.00%)
314
Buy
$270
$33.06 (13.95%)
$220
4 months 13 days ago
(26-Sep-2024)
7/9 (77.78%)
$27.44 (11.31%)
154
Hold
$200
7 months 14 days ago
(25-Jun-2024)
7/12 (58.33%)
$-17.58 (-8.08%)
84
Buy
$215
$-21.94 (-9.26%)
$215
10 months 12 days ago
(27-Mar-2024)
10/11 (90.91%)
$19.11 (9.76%)
114
Which stock is David Low is most bullish on?
What Year was the first public recommendation made by David Low?
